Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
BCL2 (show BCL2 Proteins) expression in mesennchymal lung cancer cells was induced by ERK1 (show MAPK3 Proteins) activity through the upregulation of the MEK1 (show MAP2K1 Proteins)/ERK1 (show MAPK3 Proteins) scaffold protein (show HOMER1 Proteins) MEK partner-1 (show MAPKSP1 Proteins). Interfering with the MEK1 (show MAP2K1 Proteins)/MP1/ERK1 (show MAPK3 Proteins) axis using a MEK1 (show MAP2K1 Proteins) inhibitor or MP1 depletion repressed BCL2 (show BCL2 Proteins) expression and sensitized MLCCs to chemoradiotherapy.
The authors identified two siblings carrying a homozygous PITRM1 missense mutation (c.548G>A, p.Arg183Gln) associated with an autosomal recessive, slowly progressive syndrome characterised by mental retardation, spinocerebellar ataxia, cognitive decline and psychosis.
The present study was aimed at investigating whether the miR (show MLXIP Proteins)-29c binding site single nucleotide polymorphisms within the 3'-UTRs of LAMTOR3 (show MAPKSP1 Proteins) gene affected the gastric cancer risk.
we demonstrate that the MAPK (show MAPK1 Proteins) scaffold protein (show HOMER1 Proteins) MEK partner 1 (MP1 (show MAPKSP1 Proteins)) is important for gastrin (show GAST Proteins)-induced phosphorylation of ERK1 (show MAPK3 Proteins) and ERK2 (show MAPK1 Proteins) and that MP1 promotes gastrin (show GAST Proteins)-induced proliferation of AGS (show JAG1 Proteins)-GR cells
identified polymorphisms in LAMTOR2 (show LAMTOR2 Proteins) and LAMTOR3 (show MAPKSP1 Proteins) do not seem to play a relevant role in breast cancer
Data show that the hPreP presequence only targets GFP to the matrix of mammalian and yeast mitochondria.
This study demonstrated decreased proteolytic activity of the mitochondrial amyloid-beta degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria.
A complex encoded by the MAPKSP1 (show MAPKSP1 Proteins), ROBLD3 (show LAMTOR2 Proteins), and c11orf59 (show LAMTOR1 Proteins) genes interacts with the Rag GTPases, recruits them to lysosomes, and is essential for mTORC1 activation
our data suggest that genetic variation in the hPreP gene PITRM1 may potentially contribute to mitochondrial dysfunctions
The substrate specificity of the mitochondrial metallopeptidase proteinase 1 (MP1) was investigated and its mitochondrial targeting signal identified.
results suggest that pitrilysin regulates islet amyloid polypeptide (show IAPP Proteins) in beta cells and suggest the presence of an intramitochondrial pool of islet amyloid polypeptide (show IAPP Proteins) involved in beta-cell apoptosis.
Pitrm1 is expressed in Pax3 (show PAX3 Proteins)-expressing myoblast progenitors in the limb, the dermomyotome, and developing muscles of the face and torso.
ATP-independent protease that degrades mitochondrial transit peptides after their cleavage. Also degrades other unstructured peptides. Specific for peptides in the range of 10 to 65 residues. Able to degrade amyloid beta A4 (APP) protein when it accumulates in mitochondrion, suggesting a link with Alzheimer disease. Shows a preference for cleavage after small polar residues and before basic residues, but without any positional preference.
MAPK scaffold protein 1
, MEK binding partner 1
, late endosomal/lysosomal adaptor and MAPK and MTOR activator 3
, mitogen-activated protein kinase kinase 1 interacting protein 1
, mitogen-activated protein kinase scaffold protein 1
, ragulator complex protein LAMTOR3
, PreP peptidasome
, metalloprotease 1 (pitrilysin family)
, pitrilysin metalloproteinase 1
, presequence protease, mitochondrial
, nuclear transplantation upregulated protein 1
, pitrilysin metalloprotease 1
, pitrilysin metallepetidase 1
, Pitrilysin metalloproteinase 1